Hosted on MSN1y
Dr Reddy's inks licencing pact with Pharmazz of US for innovative hypovolemic shock drug CenthaquineCenthaquine has been approved by the Drugs Controller General of India for treatment of hypovolemic shock following a successful phase III clinical trial. Hypovolemic shock can be caused by severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback